|
The Emerging Bio-IT Market: The Convergence of IT and Biopharmaceutical R&D - In-Silico High Performance Systems, Services, Opportunities and Market Published: July 2002 138 pages; Can be printed; fully searchable PDF format; TOC hyperlinks and Internet hyperlinks
SKU: TPR3138
Price: $1,995.00 (US Dollars) PDF Single User $2,995.00 (US Dollars) PDF Single Office License (2 to 5 users) $3,990.00 (US Dollars) PDF Global Site License
Description
The combination of the bioscience industry with the information technology (IT) industry is emerging as an exciting industry segment that is being called bio-IT. Bioinformatics and biocomputing are other terms that sometimes mean the same thing as bio-IT. Companies involved in this interesting industry have made it possible for several genomics companies to sequence sections of the human genome as well as do work in proteomics. The bio-IT market is emerging at an important time when the bioscience companies need enormous computing power to make sense of the flood of data that is being generated in drug discovery R&D labs. Ironically, this is also an important time for the IT industry, which is hungry for new customers in the slow economy. This report seeks to review all the key elements of this interesting and important market.
For sellers of IT, this report is a call to action for IT vendors to join into the emerging bio-IT market because opportunities are plentiful. This is unusual in a slow economy. Unlike other industries, the bioscience companies take a long term view of their business, have cash to spend on IT infrastructure, need much help from IT firms and are ready, willing and able to get started in expanding their IT infrastructures for their R&D operations. The report estimates that the bio-IT market will reach nearly $27.7 billion in 2005 with a CAGR of 31.7 percent.
Readers will learn that clusters of ordinary, yet powerful PCs running Windows or Linux can produce good computational results at a lower cost than was possible just a few years ago with big high performance computers. In-silico disease modeling is helping to predict potential drug outcomes. The web is being used to find much-needed clinical trails participants.
For potential customers, this report uses case studies of bio-IT deployments to provide a sense of what IT solutions bioscience companies require. Profiles of bio-IT vendors highlight basic information about vendors that are offering key solutions in the emerging bio-IT market. This report highlights what is driving the need for bio-IT infrastructure and why. Readers will learn about key business opportunities and the lessons learned from the bio-IT experts. This 138-page report uses more than 34 tables and figures to show the trends of this emerging field.
Table of Contents
1.The Bio-IT Market What the Bio-IT Market Represents The Impact of Life Science Facts Opportunity Roadmap for Bio-IT Market Participants Bioscience Systems Requirements Technologies for Bio-IT Computers and Networks Storage Systems Application Software Nanotechnology Drug Making Business Entering a Critical Time 2.Market Forces Drivers of Bio-IT Drug Discovery R&D Scientific Development is Fast Moving Pharma R&D Can Afford Current Computer Power Pharma Companies Progressing To Next Bio-IT Steps High Computational Requirements for Proteomics R&D Other Developments Bio-IT Software Genomic Data and Databases Databases for Protein Data Making Sense of All the Data 3.Bio-IT Solutions and Pharma R&D Hardware Solutions Bioscience Network Storage Solution Big Pharma Genomics Computing Solution Massive Linux Compute Farm Government Institute Genomics Pattern Matching Services Solutions IT Services Build Massive Compute Solution Children's Hospital Genomic Database and Services Software Solutions Big Pharma In Silico Drug Discovery R&D Efficiency Gained with Analytical Solution Clinical Trial e-Business Patient Recruitment Solution Clinical Trial Management Solution for Drug Maker 4.The Bio-IT Market and Future Outlook The Bio-IT Market and Industry Segments IT Services Servers Storage Software BioContent Bio-IT Market Size by Segment, 2001~2005 Bio-IT Total Market Size Forecast for Bio-IT R&D Market by Market Segments The Bio-IT "Services' Market Segment Bio-IT `Server' Market Segment Forecast Bio-IT `Storage' Market Segment Forecast Bio-IT `Software' Market Segment Forecast Bio-IT `BioContent' Market Segment Forecast Comparison of the Market Segment Forecasts 5.Bio-IT Future Trends Overview of Past Trends Genomics Developments That Impact on Bio-IT Computer System Advancements Future Directions IT Services Software Biocontent Servers Storage 6.Key Findings and Opportunities Problems of Drug Discovery R&D and Bio-IT Difficulty of Converting Science Bottlenecks Into Computational Problems Becoming a Low Profit Commodity The Next Hot Areas of Bio-IT Need for Bigger and More Powerful Computers Clinical Trials, Bio-IT and e-Business Growing Interest in Personalized Medicine Big Opportunities Emerging Role in Drug Discovery Data Storage and Management Consulting and e-Services Growing Fast Better Software Summary Bio-IT Vendors to Become Partners with Pharmas Increase Chances of Pharma Success with Bio-IT 7.Company Profiles of Bio-IT Suppliers BioContent Suppliers Celera Genomics Corporation Human Genome Sciences, Inc. Incyte Genomics, Inc. NuTec Sciences, Inc., Life Science Div. Application Software Suppliers Accelrys, Inc. Cellomics, Inc. InforMax, Inc. Spotfire, Inc. Hardware Systems Suppliers Compaq Computer Corporation IBM Corporation Paracel, Inc. Bio-IT Service Suppliers Blackstone Computing Entigen Corporation Linux NetworX, Inc. Systems Software Suppliers Red Hat Linux, Inc. Turbolinux, Inc. 8.Appendix 1 - Selected Suppliers 9.Appendix 2 - Bioscience Glossary
34 Tables and Figures
|
||